Literature DB >> 27226018

Omental flap after pelvic exenteration for pelvic cancer.

Yuji Miyamoto1, Takahiko Akiyama1, Yasuo Sakamoto1, Ryuma Tokunaga1, Mayuko Ohuchi1, Hironobu Shigaki1, Junji Kurashige1, Masaaki Iwatsuki1, Yoshifumi Baba1, Naoya Yoshida1, Hideo Baba2.   

Abstract

Pelvic infection is a significant clinical problem after pelvic exenteration. The clinical benefit of an omental flap in reducing the incidence of such infections is unknown. The aim of this study was to evaluate whether an omental flap after pelvic exenteration reduces the incidence of pelvic infection and the length of postoperative hospital stay. In this study, we demonstrate a safe, effective, simple method for reducing the incidence of pelvic infection using an omental flap. We performed pelvic exenteration for tumors that were suspected to have extensive invasion to the bladder, prostate, or uterus. The omentum was dissected from the transverse colon and greater curvature of the stomach. The flap was based on the right gastroepiploic vessels and tunneled in the retrocolic plane, through the mesentery of the transverse colon and ileocecum, to the defect. Twenty-seven patients were analyzed retrospectively. Ten patients received omental flaps, and 17 patients underwent pelvic exenteration without an omental flap. The incidence of pelvic infection was significantly reduced in the patients with omental flaps.

Entities:  

Keywords:  Omental flap; Pelvic exenteration; Pelvic infection

Mesh:

Year:  2016        PMID: 27226018     DOI: 10.1007/s00595-016-1348-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.

Authors:  Ramon E Jimenez; Margo Shoup; Alfred M Cohen; Philip B Paty; Jose Guillem; W Douglas Wong
Journal:  Dis Colon Rectum       Date:  2003-12       Impact factor: 4.585

2.  Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?

Authors:  Nuh N Rahbari; Alexis B Ulrich; Thomas Bruckner; Marc Münter; Axel Nickles; Pietro Contin; Thorsten Löffler; Christoph Reissfelder; Moritz Koch; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

3.  Short-term outcome after gluteus maximus myocutaneous flap reconstruction of the pelvic floor following extra-levator abdominoperineal excision of the rectum.

Authors:  C Anderin; A Martling; J Lagergren; A Ljung; T Holm
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

4.  Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.

Authors:  Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Seiichirou Yamamoto
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

5.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.

Authors:  T Holm; A Ljung; T Häggmark; G Jurell; J Lagergren
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

6.  Utility of the omentum in pelvic floor reconstruction following resection of anorectal malignancy: patient selection, technical caveats, and clinical outcomes.

Authors:  Charles S Hultman; Matthew A Sherrill; Eric G Halvorson; Clara N Lee; John F Boggess; Michael O Meyers; Benjamin A Calvo; Hong J Kim
Journal:  Ann Plast Surg       Date:  2010-05       Impact factor: 1.539

7.  Closed-suction drainage versus no drainage following radical abdominal hysterectomy with pelvic lymphadenectomy for stage IB cervical cancer.

Authors:  B Patsner
Journal:  Gynecol Oncol       Date:  1995-05       Impact factor: 5.482

8.  Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.

Authors:  Dariusz Wydra; Janusz Emerich; Sambor Sawicki; Katarzyna Ciach; Andrzej Marciniak
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 9.  Myocutaneous flap reconstruction of the pelvis after abdominoperineal excision.

Authors:  P J Nisar; H J Scott
Journal:  Colorectal Dis       Date:  2008-11-14       Impact factor: 3.788

10.  Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.

Authors:  Seiji Ishiguro; Takayuki Akasu; Shin Fujita; Seiichiro Yamamoto; Miranda Kusters; Yoshihiro Moriya
Journal:  Surgery       Date:  2008-12-23       Impact factor: 3.982

View more
  2 in total

1.  Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Takeru Matsuda; Yasuo Sumi; Kimihiro Yamashita; Hiroshi Hasegawa; Masashi Yamamoto; Yoshiko Matsuda; Shingo Kanaji; Taro Oshikiri; Tetsu Nakamura; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Int J Colorectal Dis       Date:  2018-02-13       Impact factor: 2.571

2.  Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization.

Authors:  Yuto Maeda; Yuji Miyamoto; Yukiharu Hiyoshi; Kojiro Eto; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Int Cancer Conf J       Date:  2022-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.